TOCQUEVILLE ASSET MANAGEMENT L.P. - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 225 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
TOCQUEVILLE ASSET MANAGEMENT L.P. ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$597,000
-9.5%
23,150
+69.9%
0.01%
-35.7%
Q2 2020$660,000
+14.6%
13,6250.0%0.01%0.0%
Q1 2020$576,000
-1.2%
13,6250.0%0.01%
+55.6%
Q4 2019$583,000
-51.7%
13,625
-59.4%
0.01%
-43.8%
Q3 2019$1,207,000
-34.6%
33,525
-51.5%
0.02%
-33.3%
Q2 2019$1,846,000
-26.0%
69,068
-25.6%
0.02%
-27.3%
Q1 2019$2,494,000
+197.3%
92,868
+79.0%
0.03%
+153.8%
Q4 2018$839,000
-22.1%
51,8680.0%0.01%
-7.1%
Q3 2018$1,077,000
+276.6%
51,868
+177.4%
0.01%
+250.0%
Q2 2018$286,000
-61.7%
18,700
-43.6%
0.00%
-60.0%
Q1 2018$746,000
-20.5%
33,180
+6.5%
0.01%
-9.1%
Q4 2017$938,000
-45.0%
31,160
-31.2%
0.01%
-45.0%
Q3 2017$1,705,000
-39.2%
45,260
-55.0%
0.02%
-41.2%
Q2 2017$2,805,000
-18.4%
100,560
+0.6%
0.03%
-19.0%
Q1 2017$3,436,000
+27.7%
99,950
+7.2%
0.04%
+23.5%
Q4 2016$2,690,000
-32.4%
93,275
-25.5%
0.03%
-29.2%
Q3 2016$3,980,000
-45.5%
125,125
-44.3%
0.05%
+6.7%
Q2 2016$7,298,000
+172.9%
224,800
+135.0%
0.04%
+28.6%
Q1 2016$2,674,000
+38.9%
95,650
+77.2%
0.04%
+34.6%
Q4 2015$1,925,000
+11.4%
53,990
+3.3%
0.03%
+13.0%
Q3 2015$1,728,000
-19.2%
52,240
+2.4%
0.02%
-8.0%
Q2 2015$2,138,000
+28.8%
51,040
+0.2%
0.02%
+25.0%
Q1 2015$1,660,000
+34.7%
50,940
+31.3%
0.02%
+53.8%
Q4 2014$1,232,000
+109.2%
38,800
+63.0%
0.01%
+85.7%
Q3 2014$589,000
+9.5%
23,8000.0%0.01%
+40.0%
Q2 2014$538,00023,8000.01%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Baker Brothers Advisors 27,228,338$611,821,0005.19%
First Washington CORP 176,950$3,976,0002.06%
SECTORAL ASSET MANAGEMENT INC 783,424$17,604,0001.93%
HARVEY CAPITAL MANAGEMENT INC 219,042$4,921,0001.84%
Ghost Tree Capital, LLC 400,000$8,988,0001.82%
Opus Point Partners Management, LLC 36,733$825,0001.62%
Palo Alto Investors LP 1,650,780$37,093,0001.59%
EMORY UNIVERSITY 84,714$1,904,0001.36%
GARRISON BRADFORD & ASSOCIATES INC 69,000$1,550,0001.32%
HealthCor Management, L.P. 1,378,000$30,964,0001.05%
View complete list of ACADIA PHARMACEUTICALS INC shareholders